| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/23/2006 | EP1693070A1 Procaspase 1 activation inhibitor |
| 08/23/2006 | EP1693064A1 Treating weight loss in patients suffering from inflammatory bowel diseases with S. boulardii |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1691626A1 Food and feed supplement and its use |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1381364B1 Use of mangafodipir for treating hepatocellular insufficiency |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1822879A Use of whey permeate for the treatment of metabolic syndrome |
| 08/23/2006 | CN1822835A Alkaline salts of proton pump inhibitors |
| 08/23/2006 | CN1822829A 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 08/23/2006 | CN1822828A Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 08/23/2006 | CN1821411A Method for expressing hepatitis C virus envelope protein E2 by mammal cell with high efficient secretion |
| 08/23/2006 | CN1821379A Method for preparing micrometer ginseng, pilose antler, pearl and pollen pini yang strengthening wine |
| 08/23/2006 | CN1821262A Lonicera macranthoides active total saponin extract and its preparing method and use |
| 08/23/2006 | CN1820779A Medicinal composition for treating hepatitis B and its preparing method |
| 08/23/2006 | CN1820778A Method for producing yin nourishing and life strengthening oral liquor medicine |
| 08/23/2006 | CN1820777A Process for preparing micrometer sugared shentiandiyinluyi, kidney invigorating and fatigue reducing wine |
| 08/23/2006 | CN1820773A Chinese medicine composition for treating oral inflammation and its preparation |
| 08/23/2006 | CN1820768A Process for preparing micrometer ginseng, tortoise, pearl and pollen oral liquor for nourishing yin, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820767A Process for preparing micrometer ginseng, tortoise pearl pollen granules, capsule and tablet for nourishing yin, removing fatigue and supplementing granule calcium |
| 08/23/2006 | CN1820766A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820765A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen calcium supplement granule capsule and tablet for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820757A Polyene phosphatidylcholine freeze-dried preparation injection and its preparing method |
| 08/23/2006 | CN1820746A Stepronin powder injection and its preparing method |
| 08/23/2006 | CN1820745A Stepronin injection and its preparing method |
| 08/23/2006 | CN1820741A Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 08/23/2006 | CN1820646A Health food containing paederia scandens |
| 08/23/2006 | CN1820634A Instant Job's tears seed and its preparing method |
| 08/23/2006 | CN1820618A Health preserving liver protection tea and its preparing method |
| 08/23/2006 | CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1270776C Ulcer quieting medicine its preparation and use |
| 08/23/2006 | CN1270772C Anti-hepatitis-B-virus therapeutic vaccine and its adjuvant |
| 08/23/2006 | CN1270769C Cinobufotalin lyophilized powder for injection and its preparation method |
| 08/23/2006 | CN1270764C Medicine for treating liver disease and its preparation method |
| 08/23/2006 | CN1270754C Gastropathy treating medicine and its preparation |
| 08/23/2006 | CN1270735C Externally applied ointment for treating infantile diarrhea |
| 08/23/2006 | CN1270710C Medicinal solution for treating ulceration and inflammation |
| 08/23/2006 | CN1270702C Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 08/23/2006 | CN1270701C Dexamethasone acetate plaster and its prepn. |
| 08/23/2006 | CN1270634C Soft capsule of dried oviduct fat of forest frog |
| 08/23/2006 | CN1270623C Chinese medicine composition for treating heaves and hepatitis of fowl and livestock |
| 08/23/2006 | CN1270621C Food-induced antisecretory proteins in egg yolk |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094896 Diaminothiazoles having antiproliferative activity |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094804 Water free ubiquinone concentrate |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | US7094756 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 08/22/2006 | US7094414 Famotidine injections |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
| 08/17/2006 | WO2006085143A2 Improved bioactive agent compositions for repair of cell injuries |
| 08/17/2006 | WO2006084975A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | WO2006046888A3 Preparation for curing stomatological diseases |
| 08/17/2006 | WO2006029182A3 Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183886 Ligands to enhance cellular uptake of biomolecules |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/17/2006 | US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 08/17/2006 | US20060182684 non-invasive and flexible method and carrier for drug delivery across the blood-brain barrier; brain tumors, brain metastases, stroke, schizophrenia, epilepsy, Alzheimer's, Parkinson's and Huntington's disease |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | CA2596613A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | CA2595526A1 Colonic delivery of active agents |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690539A2 Salts of tiotropium for treating inflammatory disorders |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1690533A1 Composition having liver function protective effect |
| 08/16/2006 | EP1689742A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
| 08/16/2006 | EP1689420A1 Use of g-csf for treating ischemia |
| 08/16/2006 | EP1689417A2 Moderating the effect of endotoxins |
| 08/16/2006 | EP1689408A1 Treatment of inflammatory disorders of the epithelium with low dose 2,3-benzodiazepines |